Quarterly report pursuant to Section 13 or 15(d)

Earnings Per Share (Tables)

v3.21.2
Earnings Per Share (Tables)
9 Months Ended
Sep. 30, 2021
Earnings Per Share [Abstract]  
Earnings Per Share

The following table presents computations of basic and diluted loss per share:

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 30,

 

 

September 30,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

Net loss attributable to Cinemark Holdings, Inc.

 

$

(77,814

)

 

$

(147,592

)

 

$

(428,522

)

 

$

(377,572

)

Loss allocated to participating share-based awards (1)

 

 

1,525

 

 

 

1,472

 

 

 

7,583

 

 

 

2,832

 

Net loss attributable to common stockholders

 

$

(76,289

)

 

$

(146,120

)

 

$

(420,939

)

 

$

(374,740

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Denominator (shares in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

Basic weighted average common stock outstanding

 

 

117,274

 

 

 

116,707

 

 

 

117,226

 

 

 

116,552

 

Common equivalent shares for restricted stock units (2)

 

 

 

 

 

 

 

 

 

 

 

 

Common equivalent shares for convertible notes and warrants (3)

 

 

 

 

 

 

 

 

 

 

 

 

Diluted common equivalent shares

 

 

117,274

 

 

 

116,707

 

 

 

117,226

 

 

 

116,552

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic loss per share attributable to common stockholders

 

$

(0.65

)

 

$

(1.25

)

 

$

(3.59

)

 

$

(3.22

)

Diluted loss per share attributable to common stockholders

 

$

(0.65

)

 

$

(1.25

)

 

$

(3.59

)

 

$

(3.22

)

 

(1)
For the three months ended September 30, 2021 and 2020, a weighted average of approximately 2,344 and 1,175 shares of restricted stock, respectively, were considered participating securities. For the nine months ended September 30, 2021 and 2020, a weighted average of approximately 2,112 and 880 shares of restricted stock, respectively, were considered participating securities.
(2)
For the three months ended September 30, 2021 and 2020, approximately 103 and 438, respectively, common equivalent shares for restricted stock units were excluded because they were anti-dilutive. For the nine months ended September 30, 2021 and 2020, approximately 90 and 689, respectively, common equivalent shares for restricted stock units were excluded because they were anti-dilutive.
(3)
For the three and nine months ended September 30, 2021 and 2020, diluted loss per share excludes the conversion of the 4.50% Convertible Senior Notes into 32,051 shares of common stock, as well as outstanding warrants, as they would be anti-dilutive. See further discussion below.